Dongbing Li

51PUBLICATIONS

65CO-AUTHORS

Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Genomics and transcriptomicsSolid tumoursRheumatology and arthritis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (51)

Sort by Publication Date:

|Jun 08, 2026

Unraveling the Role of miR-33a-5p in Bladder Cancer Progression: Clinical Significance and Functional Pathways.

|Jun 02, 2026

Innovations in Depression Diagnosis and Treatment: A Review of Biological, Cognitive, and Psychosocial Advances.

|May 08, 2026

CCNJL as a Prognostic Biomarker and Therapeutic Target in Cholangiocarcinoma.

|Apr 06, 2026

Decoding Sarcoma Drug Resistance: From Molecular Mechanisms to Precision Interventions.

Guizhen Lyu, Dongbing Li

|Apr 03, 2026

Research Progress on Desmoid Tumors: New Perspectives from Molecular Mechanisms to Clinical Management.

Guizhen Lyu, Yuxin Zhang, Dongbing Li

|Mar 21, 2026

From Biomarker to Drug Target: Integrating ceRNA Networks and Pharmacogenomics to Reposition C5orf34 in Uterine Corpus Endometrial Cancer Therapy.

Jiajia Yan, Xiaoming Zhu, Xiaoyan Yang

Pageof 9

Frequent Collaborators

22 joint publications

Guizhen Lyu

Yiwen Chen

Wangdong Deng

Shaoshan Li

Yibiao Chen

Yuhong Gan

Zhen Ye

Jinyuan Li

Zhichao Lin

Xingxi Pan

Frequent Collaborators

22 joint publications

Guizhen Lyu

3 joint publications

Yiwen Chen

3 joint publications

Wangdong Deng

2 joint publications

Shaoshan Li